Sort
40,608 grants matching “prostate cancer”
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma
$301,617Raphael Bueno · Brigham And Women'S Hospital · R01 · FY2008 · CA
Infrared microscopy for a systems approach to prostate pathology
$301,604Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2010 · CA
Epigenetics of Hormone Signaling in Breast Development and Cancer
$301,581Myles A Brown · Whitehead Institute For Biomedical Res · P01 · FY2016 · CA
Targeting Cathepsin L: A Novel Strategy to Impede Prostate and Breast Cancer Meta
$301,578Dietmar W Siemann · University Of Florida · R01 · FY2014 · CA
EWS/FLI AND ITS TARGETS IN EWING'S SARCOMA
$301,577Stephen L Lessnick · University Of Utah · R01 · FY2011 · CA
The role of XMRV, a newly discovered human retrovirus, in cancer pathogenesis
$301,577Ila R Singh · University Of Utah · R01 · FY2011 · CA
Epigenetics of Hormone Signaling in Breast Development and Cancer
$301,571Myles A Brown · Whitehead Institute For Biomedical Res · P01 · FY2018 · CA
Modeling Tumor Growth to Characterize Disease Heterogeneity
$301,501Kimberly D Siegmund · University Of Southern California · P01 · FY2016 · CA
Molecular analysis of metastatic prostate cancer in mice
$301,498Michael M. Shen · Columbia University Health Sciences · R01 · FY2009 · CA
Molecular analysis of metastatic prostate cancer in mice
$301,498Michael M. Shen · Columbia University Health Sciences · R01 · FY2008 · CA
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
$301,490Vanderbilt University · R01 · FY2001 · CA
Database and software development for protein-nucleic acid structure predication
$301,462Xiaoqin Zou · University Of Missouri-Columbia · R01 · FY2017 · GM
BIOLOGICALLY ACTIVE STEROID ANALOGS
$301,449Yale University · R01 · FY2001 · CA
Reactivation Methylation-Silenced Genes by Polyphenols
$301,433Rutgers The St Univ Of Nj New Brunswick · R01 · FY2004 · CA
Mechanisms and Treatment of PTEN Mutant Prostate Tumorigenesis
$301,376Lloyd C Trotman · Cold Spring Harbor Laboratory · R01 · FY2012 · CA
Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare System
$301,371Jennifer Irvin Vidrine · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Nonpeptide macrocyclic histone deacetylase (HDAC) inhibitors for targeted lung ca
$301,362Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2010 · CA
Stromal AR Roles in Prostate Hyperplasia and Cancer
$301,353Chawnshang Chang · University Of Rochester · R01 · FY2013 · CA
High Density Lipoprotein Nanoparticles for siRNA Delivery
$301,353Colby Shad Thaxton · Northwestern University At Chicago · R01 · FY2013 · CA
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence
$301,352Pamela L Paris · University Of California, San Francisco · R01 · FY2013 · CA
The Shh-Gli Pathway Regulates Prostate Growth
$301,350Wade A. Bushman · University Of Wisconsin-Madison · R01 · FY2006 · DK
Molecular Genetics of Sensory Organ Development
$301,335James W. Posakony · University Of California, San Diego · R01 · FY2014 · GM
HYPOXIA AND PRX1 IN FINASTERIDE AND SELENIUM INTERVENTION OF PROSTATE CANCER
$301,313Young-Mee Park · Roswell Park Cancer Institute Corp · P01 · FY2011 · CA
PLANT ANTITUMOR AGENTS
$301,295Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2007 · CA
The mechanism of angiogenin-induced angiogenesis
$301,286Harvard University (Medical School) · R01 · FY2005 · CA